Cargando…
Guizhi Fuling Decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS(2) technology and systems pharmacology
As one of the classical traditional Chinese medicine (TCM) prescriptions in treating gynecological tumors, Guizhi Fuling Decoction (GFD) has been used to treat breast cancer (BRCA). Nonetheless, the potential molecular mechanism remains unclear so far. Therefore, systems pharmacology was used in com...
Autores principales: | Dai, Yifei, Qiang, Weijie, Yu, Xiankuo, Cai, Siwei, Lin, Kequan, Xie, Lan, Lan, Xun, Wang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260686/ https://www.ncbi.nlm.nih.gov/pubmed/32489526 http://dx.doi.org/10.1016/j.csbj.2020.05.004 |
Ejemplares similares
-
The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation
por: Gao, Jie, et al.
Publicado: (2022) -
Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
por: Zhang, Siqin, et al.
Publicado: (2021) -
A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids
por: Zeng, Liuting, et al.
Publicado: (2017) -
Fuling-Guizhi Herb Pair in Coronary Heart Disease: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
por: Duan, Bailu, et al.
Publicado: (2020) -
Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis
por: Wang, Haoxian, et al.
Publicado: (2021)